| CWGCX | NUGCX | CWGCX / NUGCX | |
| Total Expense Ratio | 1.48 | 1.90 | 78% |
| Annual Report Gross Expense Ratio | 1.48 | 2.66 | 56% |
| Fund Existence | 25 years | 14 years | - |
| Gain YTD | 15.328 | 3.531 | 434% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 2500 | 10% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 160B | 16.6M | 963,855% |
| Annual Yield % from dividends | 0.75 | 0.71 | 105% |
| Returns for 1 year | 20.44 | 2.03 | 1,007% |
| Returns for 3 years | 43.62 | 16.62 | 262% |
| Returns for 5 years | 32.85 | 13.97 | 235% |
| Returns for 10 years | 95.24 | 45.40 | 210% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WBSNX | 32.41 | 0.87 | +2.76% |
| William Blair Small Cap Growth N | |||
| IEOPX | 15.05 | 0.27 | +1.83% |
| Voya Large Cap Growth Port A | |||
| TSVAX | 22.54 | 0.34 | +1.53% |
| PGIM Quant Solutions Small-Cap Val A | |||
| BIPIX | 80.88 | 1.14 | +1.43% |
| ProFunds Biotechnology UltraSector Inv | |||
| OIEFX | 26.73 | 0.06 | +0.22% |
| JPMorgan Equity Income R2 | |||